verratherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: | ||
Meta Tags
| Title | Verra |
| Description | Confronting Human Protease-Driven More Confronting Human Protease-Driven Diseases Confronting Human Protease-Driven Diseases Confronting Human Protease-Driven Diseases Confronting Human Pr |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 198.71.232.3 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
verratherapeutics.com Valuation
|
US$910
Last updated: 2023-05-20 08:19:48
verratherapeutics.com has Semrush global rank of 0. verratherapeutics.com has an estimated worth of US$ 910, based on its estimated Ads revenue. verratherapeutics.com receives approximately 105 unique visitors each day. Its web server is located in United States, with IP address 198.71.232.3. According to SiteAdvisor, verratherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$910 |
| Daily Ads Revenue | US$0 |
| Monthly Ads Revenue | US$25 |
| Yearly Ads Revenue | US$302 |
| Daily Unique Visitors | 7 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| verratherapeutics.com. | A | 3599 | IP: 198.71.232.3 |
| verratherapeutics.com. | NS | 3600 | NS Record: ns01.domaincontrol.com. |
| verratherapeutics.com. | NS | 3600 | NS Record: ns02.domaincontrol.com. |
| verratherapeutics.com. | MX | 3600 | MX Record: 0 verratherapeutics-com.mail.protection.outlook.com. |
| verratherapeutics.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
| verratherapeutics.com. | TXT | 3600 | TXT Record: MS=ms34347883 |
HtmlToTextCheckTime:2023-05-20 08:19:48
| More Confronting Human Protease-Driven Diseases Confronting Human Protease-Driven Diseases Confronting Human Protease-Driven Diseases Confronting Human Protease-Driven Diseases Verra transforms the treatment of major unsolved illnesses using an innovative small protein platform. About Us Verra Therapeutics is a privately held company near Ithaca NY, that was founded in 2017 with a mission of transforming the treatment of protease-driven diseases using an innovative small protein platform. Verra is developing preclinical drug candidates for Chronic Bronchitis, Acute Lung Injury and Acute Kidney Injury by adapting nature’s highly evolved design for each target protease. Dr. Christopher Prince brings decades of leadership experience to the team in managing technology companies through biotech and pharmaceutical development. Dr. Marcia Moss has a comprehensive background in drug discovery and development and is a thought leader on proteases as disease targets. Verra’s goal is to create |
HTTP Headers
HTTP/1.1 302 Found Connection: close Pragma: no-cache cache-control: no-cache Location: / HTTP/1.1 301 Moved Permanently location: https://verratherapeutics.com/ Vary: Accept-Encoding Server: DPS/1.13.2 X-SiteId: 2000 Set-Cookie: dps_site_id=2000; path=/ Date: Thu, 26 Jan 2023 09:16:51 GMT Connection: keep-alive Keep-Alive: timeout=5 HTTP/2 404 content-type: text/html;charset=utf-8 content-length: 964 vary: Accept-Encoding server: DPS/1.13.2 x-siteid: 2000 set-cookie: dps_site_id=2000; path=/; secure date: Thu, 26 Jan 2023 09:16:51 GMT |